DNA oxidative damage of neoplastic rat liver lesions

Oncology Reports

Volumn 23, Issue 5, 2010, Pages 1241-1246

  Marengo, Barbara ^a   Ciucis, Chiara De ^b   Ricciarelli, Roberta ^b   Romano, Paola ^b   Passalacqua, Mario ^b   Marinari, Umberto M ^b   Pronzato, Maria A ^b   Domenicotti, Cinzia ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

DNA oxidative damage; Glutathione; Hepatocellular carcinoma

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; MANGANESE SUPEROXIDE DISMUTASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BROWN NORWAY RAT; CONTROLLED STUDY; DNA DAMAGE; FISHER 344 RAT; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER REGENERATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRECANCER; PRIORITY JOURNAL; RAT; RAT STRAIN; TUMOR PROMOTION; TUMOR VASCULARIZATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DEOXYGUANOSINE; DISEASE PROGRESSION; DNA DAMAGE; GLUTATHIONE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; PHENOTYPE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED BN; RATS, INBRED F344; SPECIES SPECIFICITY; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 77950823117     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000756     Document Type: Article

References (27)

1. Farber E and Sarma DS: Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 56: 4-22, 1987.
2. De Miglio MR, Virdis P, Calvisi DF, Frau M, Muroni MR, Simile MM, Daino L, Careddu GM, Sanna-Passino E, Pascale RM and Feo F: Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat. Cancer Res 66: 10384-10390, 2006. (Pubitemid 44799758)
3. Beckman KB and Ames BN: Oxidative decay of DNA. J Biol Chem 272: 19633-19636, 1997.
4. Yamaguchi R, Hirano T, Asami S, Chung MH, Sugita A and Kasai H: Increased 8-hydroxyguanine levels in DNA and its repair activity in rat kidney after administration of a renal carcinogen, ferric nitrilotriacetate. Carcinogenesis 17: 2419-2422, 1996. (Pubitemid 26402241)
5. Nakae D, Kobayashi Y, Akai H, Andoh N, Satoh H, Ohashi K, Tsutsumi M and Konishi Y: Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res 57: 1281-1287, 1997. (Pubitemid 27152552)
6. Hayes JD and McLellan LI: Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 31: 273-300, 1999.
7. Obrador E, Navarro J, Mompo J, Asensi M, Pellicer JA and Estrela JM: Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo. Biochem J 325 (Pt 1): 183-189, 1997. (Pubitemid 27322702)
8. Johnson F and Giulivi C: Superoxide dismutases and their impact upon human health. Mol Aspects Med 26: 340-352, 2005. (Pubitemid 41225357)
9. Pascale RM, Simile MM, DeMiglio MR, Muroni MR, Gaspa L, Dragani TA and Feo F: The BN rat strain carries dominant hepatocarcinogen resistance loci. Carcinogenesis 17: 1765-1768, 1996. (Pubitemid 26280406)
10. Solt DB, Medline A and Farber E: Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am J Pathol 88: 595-618, 1977. (Pubitemid 8202940)
11. Senft AP, Dalton TP and Shertzer HG: Determining glutathione and glutathione disulfide using the fluorescence probe ophthalaldehyde. Anal Biochem 280: 80-86, 2000.
12. Feo F, De Miglio MR, Simile MM, Muroni MR, Calvisi DF, Frau M and Pascale RM: Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition. Biochim Biophys Acta 1765: 126-147, 2006.
13. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
14. Ushio-Fukai M and Nakamura Y: Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266: 37-52, 2008. (Pubitemid 351753035)
15. Kaplowitz N: Mechanisms of liver cell injury. J Hepatol 32: 39-47, 2000.
16. Tanaka H, Fujita N, Sugimoto R, Urawa N, Horiike S, Kobayashi Y, Iwasa M, Ma N, Kawanishi S, Watanabe S, Kaito M and Takei Y: Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C. Br J Cancer 98: 580-586, 2008. (Pubitemid 351214532)
17. Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y and Asaka M: 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 23: 1431-1436, 2008.
18. Ghibelli L, Fanelli C, Rotilio G, Lafavia E, Coppola S, Colussi C, Civitareale P and Ciriolo MR: Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J 12: 479-486, 1998. (Pubitemid 28146527)
19. Terradez P, Asensi M, Lasso de la Vega MC, Puertes IR, Vina J and Estrela JM: Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth. Biochem J 292 (Pt 2): 477-483, 1993. (Pubitemid 23181962)
20. Friesen C, Kiess Y and Debatin KM: A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Cell Death Differ 11 (Suppl. 1): S73-S85, 2004. (Pubitemid 39136800)
21. Shen H, Kauvar L and Tew KD: Importance of glutathione and associated enzymes in drug response. Oncol Res 9: 295-302, 1997. (Pubitemid 127825983)
22. Perquin M, Oster T, Maul A, Froment N, Untereiner M and Bagrel D: The glutathione-related detoxification pathway in the human breast: a highly coordinated system disrupted in the tumour tissues. Cancer Lett 158: 7-16, 2000. (Pubitemid 30625225)
23. Navarro J, Obrador E, Carretero J, Petschen I, Avino J, Perez P and Estrela JM: Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic Biol Med 26: 410-418, 1999. (Pubitemid 29013473)
24. Zhong W, Oberley LW, Oberley TD and St Clair DK: Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 14: 481-490, 1997. (Pubitemid 27087111)
25. Oberley LW: Anticancer therapy by overexpression of superoxide dismutase. Antioxid Redox Signal 3: 461-472, 2001.
26. Weydert CJ, Waugh TA, Ritchie JM, Iyer KS, Smith JL, Li L, Spitz DR and Oberley LW: Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic Biol Med 41: 226-237, 2006. (Pubitemid 43928496)
27. Owusu-Ansah E and Banerjee U: Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 461: 537-541, 2009.